Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-24 @ 7:11 PM
NCT ID:
NCT00305903
Eligibility Criteria:
Inclusion Criteria:
* Have a diagnosis of probable Alzheimer's disease;
* Have an MMSE score between 10 and 20;
* Must be able to swallow capsule/tablet;
* Must have a caregiver who is able to attend all study visits;
Exclusion Criteria:
* Have an advanced, severe, progressive, or unstable disease of any type that may interfere with efficacy and safety assessments or put the patient at special risk;
* Have a current diagnosis of active, uncontrolled seizure disorder;
* Have a history within the past year or current diagnosis of cerebrovascular disease
* Have a current diagnosis of severe or unstable cardiovascular disease;
* Had a myocardial infarction (MI) within the last six months;
* Have specific respiratory, digestive, renal, or endocrine disorders;
* Have had previous treatment with rivastigmine or memantine;
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
85 Years
Study:
NCT00305903
Study Brief:
Protocol Section:
NCT00305903